Time for lockdown stocks again?
investingLive • • health
Key Points:
- In 2024, fears of a mutated monkeypox virus sparked concerns of a new pandemic, but effective vaccines like JYNNEOS prevented widespread impact, keeping major stock indexes stable.
- Currently, media attention is focused on hantavirus following deaths and illnesses aboard the MV Hondius expedition ship, though experts and WHO officials report no evidence of widespread transmission or need for quarantines.
- The Andean strain of hantavirus detected has a high fatality rate (20-40%) but is not airborne, limiting its potential to become a global pandemic unless a new airborne variant emerges.
- Despite frequent outbreaks globally, governments are unlikely to impose drastic measures like border closures or lockdowns for each incident, as such responses would severely disrupt the global economy.
- Market focus remains on geopolitical risks in the Strait of Hormuz and the AI sector’s performance, with recent vaccine stock rallies viewed as short-term speculation rather than indicators of a looming health crisis.